Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals Cognes Medical Solutions is thrilled to announce its selection as one of the Top 100 companies advancing to the prestigious Entrepreneurship World Cup (EWC) Global Finals. Cognes will join an elite group of startups from 52 countries competing for […]
Cognes Medical Solutions Advances to Next Phase of the Entrepreneurship World Cup
Company will compete for a trip to the Global Finals and a share of $US1M in cash prizes
Cognes to Entrepreneurship World Cup Top 250 Read More »
Alzheimer’s disease, a formidable adversary in the realm of neurodegenerative diseases, affects millions worldwide, presenting a significant challenge to both those diagnosed and their loved ones. The quest for effective treatments has long been fraught with the complexities of gauging their true impact. However, a groundbreaking perspective suggesting a major overhaul in how we assess
Alzheimer’s Treatment Assessment: Innovative Strategies for Optimal Results Read More »
On March 20, 2024, the European Patent Office (EPO) officially granted Cognes Medical Solutions AB a patent for its novel method and system for non-invasive estimation of dementia progression. This novel approach, which utilizes imaging technology to capture and analyze images of a subject’s head from various angles, has the potential to improve early detection
While the Cognes app is not a replacement for a registered medical practitioner’s diagnosis, it is a valuable tool in identify early-stage Dementia patients.
Amazing Breakthroughs in Dementia & Alzheimer’s treatment & diagnosis Read More »
One of the most significant causes of dementia in the modern world is Alzheimer’s. Yet even though many people are suffering from this terrible disease, there are many challenges in diagnosing Alzheimer’s dementia. Often this is because many of the common symptoms that show up early tend to correspond with other disorders within the neurodegenerative disorder family.
Assessing Memory Impairment: Alzheimer’s Diagnostics and Treatments of the Future Read More »
Alzheimer’s disease is one of the most common forms of dementia. Many people wonder if Alzheimer’s disease is preventable. Based on extensive research, many factors contribute to the development of the disease. This includes environmental factors, genetics, age, and existing medical conditions. Many risk factors, like genetics and age, can’t be changed.
Effects Of Alzheimer’s Disease On The Brain Read More »
Alzheimer’s disease is one of the most common forms of dementia. Many people wonder if Alzheimer’s disease is preventable. Based on extensive research, many factors contribute to the development of the disease. This includes environmental factors, genetics, age, and existing medical conditions. Many risk factors, like genetics and age, can’t be changed.
How to Reduce The Risk Of Alzheimer’s Disease Read More »
Today, Alzheimer’s is one of the most prevalent diseases in America, affecting about 11.3% of all people aged 65 years and over. In 2021, there were about 6.2 million people with Alzheimer’s, with the number expected to more than double and reach 13 million by 2050 should a cure not be found. It typically affects the seniors, with 72% of the 6.2 million people living with Alzheimer’s being over 75 years old.
Unraveling Alzheimer’s: Confronting the Effect on Mortality Read More »
In 2021, more than 6 million people were living with Alzheimer’s in the US. This number is projected to more than double to over 13 million by 2050. Despite the exceedingly high number of Alzheimer’s patients, the cost of diagnosis and treatment is also very high, making it one of the costliest ailments in the world. As a result, proper diagnosis and treatment are way off the reach of thousands of Americans, with this number also projected to rise.
Alzheimer’s Diagnosis Accessibility: A Need for Earlier Diagnosis and a Better Life Read More »
